The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vasculitis Guidelines in Focus, Part 1: The Guideline Project

Vasculitis Guidelines in Focus, Part 1: The Guideline Project

August 31, 2021 • By Michael Putman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In 2021, the ACR—in concert with the Vasculitis Foundation (VF)—released four new vasculitis guidelines, one each on: 1) anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, 2) giant cell arteritis (GCA) and Takayasu arteritis, 3) polyarteritis nodosa and 4) Kawasaki disease.1-3,5 The guideline development process is complex. For the vasculitis guidelines, this process kicked off in June 2017, when the core leadership team formed by the ACR first met in person. The ACR also convened expert and voting panels. Together, the core team and the two panels determined the project’s scope. Members of the literature review team assembled evidence using the most recent nomenclature system for vasculitis, the 2012 Chapel Hill Consensus Conference nomenclature.4 A panel of patients contributed as well. In this series, we discuss the updated recommendations with authors who contributed to each guideline. Read other installments in this series.

You Might Also Like
  • Vasculitis Guidelines in Focus, Part 2: ANCA-Associated Vasculitis
  • Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa
  • Vasculitis Guidelines in Focus, Part 5: Takayasu Arteritis
Explore This Issue
April 2010, September 2021

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

First up in this series, we talk with Sharon A. Chung, MD, MAS, about the overall vasculitis guideline effort. Dr. Chung is director of the vasculitis clinic at the University of California, San Francisco, and served as the principal investigator of the overall vasculitis guideline effort.

Q: Guidelines can be helpful in a lot of ways, and I think different people use them in different ways, depending on who they are, how they practice and how comfortable they are with diseases. How do you see these particular guidelines impacting clinical practice?

Dr. Chung

Dr. Chung: The vasculitides aren’t the most common rheumatic diseases, and many practitioners may not have much experience caring for patients with vasculitis. Therefore, the first goal is to have these guidelines serve as a resource for clinicians—in essence, a road map to guide practitioners on how to treat patients with specific types of vasculitis.

The second goal is to help clinicians think about factors that should influence the types of therapies to choose. In these guidelines, we provide alternatives to the recommended treatments and factors to consider when thinking about these alternatives.

The third purpose is to point out where we have gaps in knowledge, and to light a fire under someone to say, ‘Wow, that’ a really important question, and we really should look into it!’ That way, we have more information to make better treatment recommendations the next time.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Q: I’m curious about the process itself: How are people selected, and how did you get to recommendations? What did this look like behind the scenes?

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Guidelines, Vasculitis Tagged With: Guidelines, Vasculitis, Vasculitis FoundationIssue: April 2010, September 2021

You Might Also Like:
  • Vasculitis Guidelines in Focus, Part 2: ANCA-Associated Vasculitis
  • Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa
  • Vasculitis Guidelines in Focus, Part 5: Takayasu Arteritis
  • Vasculitis Guidelines in Focus, Part 6: Giant Cell Arteritis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)